In pandemic lesson, drug maker Stada turns to China for supply security
  • Stada seeking partnerships in mainland to bolster raw material supplies, sales in Asia’s biggest pharmaceutical market
  • Move in Asia follows recent aggressive acquisitions of assets in Russia, Ukraine markets
4 Jun 2020 - 11:17AM